Animal vaccine for MERS might be the best approach, experts say

09/12/2013 | Canada.com

It might be more advantageous for scientists to produce a Middle East respiratory syndrome coronavirus vaccine for animals suspected to be part of the human transmission chain rather than develop a human vaccine, according to some infectious disease specialists. The cost and time involved in obtaining regulatory approval are limiting factors for human vaccine development, while animal vaccine development is more time- and cost-effective. Animal vaccines are an underused way to protect people from zoonotic disease, says physician Tom Monath, a founder of the One Health Initiative.

View Full Article in:

Canada.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY